treosulfan has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, J; Fraser, C; Keogh, SJ; Kohli, S; Lee, S; McLachlan, AJ; Nath, CE; O'Brien, T; Rosser, SPA; Shaw, PJ | 1 |
| Bertaina, A; Guchelaar, HJ; Lankester, AC; Locatelli, F; Moes, DJAR; van der Stoep, MYEC; Zwaveling, J | 1 |
| Baumgart, J; Becker, M; Fichtner, I | 1 |
3 other study(ies) available for treosulfan and Body Weight
| Article | Year |
|---|---|
Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations.
Topics: Adolescent; Body Weight; Busulfan; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Infant; Prospective Studies | 2023 |
Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Age Factors; Antineoplastic Agents, Alkylating; Biological Variation, Population; Body Weight; Busulfan; Child; Child Development; Child, Preschool; Datasets as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Metabolic Clearance Rate; Models, Biological; Predictive Value of Tests; Prospective Studies; Transplantation Conditioning | 2019 |
Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL).
Topics: Animals; Antineoplastic Agents, Alkylating; Body Weight; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Hematologic Diseases; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Heterologous | 2003 |